Fisher & Paykel Healthcare Corporation Limited (ASX: FPH)
Australia
· Delayed Price · Currency is AUD 33.22
+0.27 (0.82%)
Nov 7, 2024, 4:10 PM AEST
FPH Income Statement
Financials in millions NZD. Fiscal year is April - March.
Millions NZD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Revenue | 1,743 | 1,743 | 1,581 | 1,682 | 1,971 | 1,264 | Upgrade
|
| Revenue Growth (YoY) | 10.23% | 10.23% | -5.98% | -14.69% | 55.99% | 18.06% | Upgrade
|
| Cost of Revenue | 698.4 | 698.4 | 642.7 | 629 | 725.6 | 427.9 | Upgrade
|
| Gross Profit | 1,044 | 1,044 | 938.4 | 1,053 | 1,246 | 835.8 | Upgrade
|
| Selling, General & Admin | 492.8 | 492.8 | 431.9 | 393.1 | 396.6 | 338 | Upgrade
|
| Research & Development | 198.2 | 198.2 | 174.3 | 154 | 136.7 | 118.5 | Upgrade
|
| Operating Expenses | 691 | 691 | 606.2 | 547.1 | 533.3 | 456.5 | Upgrade
|
| Operating Income | 353.4 | 353.4 | 332.2 | 505.6 | 712.3 | 379.3 | Upgrade
|
| Interest Expense | -18.2 | -18.2 | -6.7 | -4.9 | -5 | -3.9 | Upgrade
|
| Interest & Investment Income | 3.3 | 3.3 | 2.6 | 2.6 | 1.5 | 2.2 | Upgrade
|
| Currency Exchange Gain (Loss) | -4.7 | -4.7 | -0.1 | 0.9 | 9.4 | -7.1 | Upgrade
|
| EBT Excluding Unusual Items | 333.8 | 333.8 | 328 | 504.2 | 718.2 | 370.5 | Upgrade
|
| Asset Writedown | -98.1 | -98.1 | - | - | - | - | Upgrade
|
| Pretax Income | 235.7 | 235.7 | 328 | 504.2 | 718.2 | 370.5 | Upgrade
|
| Income Tax Expense | 103.1 | 103.1 | 77.7 | 127.3 | 194 | 83.2 | Upgrade
|
| Net Income | 132.6 | 132.6 | 250.3 | 376.9 | 524.2 | 287.3 | Upgrade
|
| Net Income to Common | 132.6 | 132.6 | 250.3 | 376.9 | 524.2 | 287.3 | Upgrade
|
| Net Income Growth | -47.02% | -47.02% | -33.59% | -28.10% | 82.46% | 37.33% | Upgrade
|
| Shares Outstanding (Basic) | 582 | 582 | 578 | 577 | 576 | 574 | Upgrade
|
| Shares Outstanding (Diluted) | 586 | 586 | 582 | 580 | 580 | 579 | Upgrade
|
| Shares Change (YoY) | 0.78% | 0.78% | 0.28% | 0.07% | 0.09% | 0.17% | Upgrade
|
| EPS (Basic) | 0.23 | 0.23 | 0.43 | 0.65 | 0.91 | 0.50 | Upgrade
|
| EPS (Diluted) | 0.23 | 0.23 | 0.43 | 0.65 | 0.90 | 0.50 | Upgrade
|
| EPS Growth | -47.44% | -47.44% | -33.85% | -28.10% | 82.26% | 37.02% | Upgrade
|
| Free Cash Flow | 112.8 | 112.8 | 50.4 | 185.9 | 465.1 | 176.1 | Upgrade
|
| Free Cash Flow Per Share | 0.19 | 0.19 | 0.09 | 0.32 | 0.80 | 0.30 | Upgrade
|
| Dividend Per Share | 0.415 | 0.415 | 0.405 | 0.395 | 0.380 | 0.275 | Upgrade
|
| Dividend Growth | 2.47% | 2.47% | 2.53% | 3.95% | 38.18% | 18.28% | Upgrade
|
| Gross Margin | 59.93% | 59.93% | 59.35% | 62.60% | 63.19% | 66.14% | Upgrade
|
| Operating Margin | 20.28% | 20.28% | 21.01% | 30.06% | 36.14% | 30.02% | Upgrade
|
| Profit Margin | 7.61% | 7.61% | 15.83% | 22.41% | 26.59% | 22.73% | Upgrade
|
| Free Cash Flow Margin | 6.47% | 6.47% | 3.19% | 11.05% | 23.59% | 13.94% | Upgrade
|
| EBITDA | 444.8 | 444.8 | 409.5 | 578.5 | 781.3 | 425.6 | Upgrade
|
| EBITDA Margin | 25.52% | 25.52% | 25.90% | 34.40% | 39.64% | 33.68% | Upgrade
|
| D&A For EBITDA | 91.4 | 91.4 | 77.3 | 72.9 | 69 | 46.3 | Upgrade
|
| EBIT | 353.4 | 353.4 | 332.2 | 505.6 | 712.3 | 379.3 | Upgrade
|
| EBIT Margin | 20.28% | 20.28% | 21.01% | 30.06% | 36.14% | 30.02% | Upgrade
|
| Effective Tax Rate | 43.74% | 43.74% | 23.69% | 25.25% | 27.01% | 22.46% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.